Stoke Therapeutics, Inc. (STOK) Return On Assets % [USD] 2020 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Stoke Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2024.
  • Stoke Therapeutics, Inc. Return On Assets for the quarter ending March 31, 2024 was -46.7 %, a 31.7% decline year-over-year.
  • Stoke Therapeutics, Inc. annual Return On Assets for 2023 was -41.6 %, a 18.4% decline from 2022.
  • Stoke Therapeutics, Inc. annual Return On Assets for 2022 was -35.1 %, a 6.01% decline from 2021.
  • Stoke Therapeutics, Inc. annual Return On Assets for 2021 was -33.1 %, a 47.3% decline from 2020.
Return On Assets, Quarterly (% [USD])
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -46.7 -11.2 -31.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -41.6 -6.47 -18.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -40 -4.74 -13.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -39.2 -4.43 -12.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -35.4 -0.53 -1.52% Jan 1, 2023 Mar 31, 2023
Q4 2022 -35.1 -1.99 -6.01% Oct 1, 2022 Dec 31, 2022
Q3 2022 -35.2 -7.5 -27% Jul 1, 2022 Sep 30, 2022
Q2 2022 -34.7 -8.98 -34.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -34.9 -11.4 -48.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -33.1 -10.6 -47.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -27.7 -5.47 -24.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -25.7 -6.71 -35.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -23.5 -7.41 -46% Jan 1, 2021 Mar 31, 2021
Q4 2020 -22.5 Oct 1, 2020 Dec 31, 2020
Q3 2020 -22.3 Jul 1, 2020 Sep 30, 2020
Q2 2020 -19 Apr 1, 2020 Jun 30, 2020
Q1 2020 -16.1 Jan 1, 2020 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.